P/E ratio for bioMérieux (BIM.PA)
P/E ratio at the end of 2021: 24.7
According to bioMérieux's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2021 the company had a P/E ratio of 24.7.
P/E ratio history for bioMérieux from 2005 to 2021
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 24.7 | -27.51% |
| 2020 | 34.1 | -1.29% |
| 2019 | 34.6 | 35.05% |
| 2018 | 25.6 | -30.77% |
| 2017 | 37.0 | 254.9% |
| 2016 | 10.4 | -73.54% |
| 2015 | 39.4 | 57.37% |
| 2014 | 25.0 | 37.59% |
| 2013 | 18.2 | -14.31% |
| 2012 | 21.2 | 54.06% |
| 2011 | 13.8 | -27.18% |
| 2010 | 18.9 | -13.83% |
| 2009 | 22.0 | 19.67% |
| 2008 | 18.3 | -42.98% |
| 2007 | 32.2 | 66.34% |
| 2006 | 19.3 | -1.04% |
| 2005 | 19.5 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.